128 related articles for article (PubMed ID: 34056010)
1. Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort.
Douma B; Ben Younes T; Benrhouma H; Miladi Z; Zamali I; Rouissi A; Klaa H; Kraoua I; Ben Ahmed M; Ben Youssef Turki I
J Immunol Res; 2021; 2021():6666117. PubMed ID: 34056010
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis.
Kelly MJ; Grant E; Murchison AG; Binks S; Ramanathan S; Michael S; Handel AE; Handunnetthi L; Uy CE; Soltys JN; Dubey D; Day GS; Lopez-Chiriboga AS; Flanagan EP; Sheerin F; Irani SR
JAMA Neurol; 2024 May; 81(5):525-533. PubMed ID: 38497971
[TBL] [Abstract][Full Text] [Related]
3. The role of immunoglobulin in cerebrospinal fluid on the differential diagnosis of autoimmune encephalitis and viral encephalitis in children.
Hu X; Cheng S
BMC Pediatr; 2024 Jun; 24(1):386. PubMed ID: 38851704
[TBL] [Abstract][Full Text] [Related]
4. Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures.
Rafferty T; Koeppen-Babcock A; Muppidi S; Li Y; Le S
Epilepsy Behav; 2024 May; 154():109737. PubMed ID: 38518672
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in a case of low titre GAD65 antibody-associated spectrum neurological disorders.
Wei M; Bannout F; Dastjerdi M; Phan C; Batarseh S; Guo X; Baker N
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38871638
[TBL] [Abstract][Full Text] [Related]
6. Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin.
Lin Z; Zhou F; Ni L; Dong S; Fu G; Zhao J
Front Immunol; 2024; 15():1338714. PubMed ID: 38469308
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune encephalitis in glial fibrillary acidic protein astrocytopathy.
Zhao CW; Gheihman G; Nigam M; Manzano GS
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38724215
[TBL] [Abstract][Full Text] [Related]
8. Mimickers of autoimmune encephalitis: a literature review.
Alshutaihi MS; Mazketly M; Tabbakh M; Akkash N; Bahro T; Alsaman MZB
J Int Med Res; 2024 May; 52(5):3000605241248050. PubMed ID: 38775376
[TBL] [Abstract][Full Text] [Related]
9. Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis.
Ruiz-García R; Muñoz-Sánchez G; Naranjo L; Guasp M; Sabater L; Saiz A; Dalmau J; Graus F; Martinez-Hernandez E
Front Immunol; 2021; 12():691536. PubMed ID: 34267758
[TBL] [Abstract][Full Text] [Related]
10. Management of Autoimmune Encephalitis in a 7-Year-Old Child With CTLA-4 Haploinsufficiency and AMPA Receptor Antibodies: A Case Report.
Quaak MSW; Buijze MSJS; Verhoeven VJM; Vermont C; Buddingh EP; Heredia M; Samsom JN; Titulaer MJ; van Rossum AM; Kamphuis S; Neuteboom RF
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200254. PubMed ID: 38728609
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of seizure-predominant autoimmune encephalitis and utility of anti-neuronal antibody scores for early treatment].
Tanemoto M; Suzuki S; Yokokawa K; Saito T; Iwahara N; Tsuda R; Watanabe O; Takahashi Y; Yoneda M; Hisahara S
Rinsho Shinkeigaku; 2024 Apr; 64(4):272-279. PubMed ID: 38508734
[TBL] [Abstract][Full Text] [Related]
12. [The diagnostic challenge of autoimmune encephalitis].
Di Liberto G; Uginet M; Lalive PH; Du Pasquier R
Rev Med Suisse; 2024 Apr; 20(871):822-827. PubMed ID: 38665101
[TBL] [Abstract][Full Text] [Related]
13. Case report: Shingles-associated probable Bickerstaff brainstem encephalitis with IgM anti-sulfatide positivity.
Fu X; Zhan Q; Zhang L; Tian X
Front Immunol; 2024; 15():1358886. PubMed ID: 38660303
[TBL] [Abstract][Full Text] [Related]
14. Safety of Obinutuzumab in Children With Autoimmune Encephalitis and Early B-Cell Repopulation on Rituximab.
Nguyen AT; Cotteret C; Gins C; Sarda E; Durrleman C; Mesples B; Bustamante J; Fayard C; Cisternino S; Desguerre I; Aubart M
Pediatr Neurol; 2024 Jul; 156():79-84. PubMed ID: 38733858
[TBL] [Abstract][Full Text] [Related]
15. Update on the diagnosis and management of autoimmune encephalitis.
Ellul MA; Wood G; Tooren HVD; Easton A; Babu A; Michael BD
Clin Med (Lond); 2020 Jul; 20(4):389-392. PubMed ID: 32675144
[TBL] [Abstract][Full Text] [Related]
16. CD8 encephalitis presenting as autoimmune encephalitis in HIV-1 infection.
Wood AC; Parker R; Allinson K; Scoffings D
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35459644
[TBL] [Abstract][Full Text] [Related]
17. Therapy response in seronegative versus seropositive autoimmune encephalitis.
Berger B; Hauck S; Runge K; Tebartz van Elst L; Rauer S; Endres D
Front Immunol; 2023; 14():1196110. PubMed ID: 37325671
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor-associated autoimmune encephalitis-an emerging cause for encephalitis.
Herath TM; Mbydeen THS; Saleh M; Sunil Wimalaratna SW
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38839410
[No Abstract] [Full Text] [Related]
19. Autoimmune and inflammatory neurological disorders in the intensive care unit.
Legouy C; Cervantes A; Sonneville R; Thakur KT
Curr Opin Crit Care; 2024 Apr; 30(2):142-150. PubMed ID: 38441114
[TBL] [Abstract][Full Text] [Related]
20. Language impairments in seropositive and seronegative autoimmune encephalitis.
Griffith SP; Wesselingh R; D'Aprano F; Seery N; Rushen T; Kyndt C; Long B; Seneviratne U; Kalincik T; Buzzard K; Butzkueven H; O'Brien TJ; Alpitsis R; Malpas CB; Monif M;
Neurol Sci; 2024 Jul; 45(7):3389-3398. PubMed ID: 38358549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
